Senior Director
Abata Therapeutics
Watertown, Massachusetts, United States
Dr. Devan Moodley is a biotech leader with a Ph.D. in Immunology/Biochemistry and a passion for translating scientific innovation into impactful solutions. Currently serving as the Senior Director and Head of Clinical Sciences at Abata Therapeutics in Massachusetts, USA, Dr. Moodley has been instrumental in building the company from its inception, leading the development of cutting-edge research strategies and infrastructure.
Dr. Moodley has previously held key positions at Surface Oncology and Third Rock Ventures, contributing significantly to the advancement of various programs and the establishment of research platforms. His expertise spans systems immunology, data science, and team leadership, showcasing a unique ability to bridge the gap between scientific disciplines.
Beyond his corporate roles, Dr. Moodley has made substantial contributions to academia, having served as a Postdoctoral Fellow at Harvard Medical School and Adjunct Faculty at the University of KwaZulu Natal in South Africa. His research has delved into diverse areas, from cytokine signatures to microbiome studies, reflecting a holistic approach to understanding complex biological systems.
A recipient of prestigious awards, including the Mail and Guardian Top 200 Young South African, Dr. Devan Moodley continues to drive innovation and excellence in the field of biotechnology, leaving an indelible mark on both the scientific and corporate landscapes.
Disclosure information not submitted.
TCR Engineered Tregs for Autoimmune Diseases
Thursday, June 20, 2024
1:40 PM – 2:05 PM PT
